# HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe Insomnia

> **NCT07659366** · NA · NOT_YET_RECRUITING · sponsor: **Nexalin Technology** · enrollment: 160 (estimated)

## Conditions studied

- Moderate to Severe Insomnia

## Interventions

- **DEVICE:** Transcranial alternating current stimulator

## Key facts

- **NCT ID:** NCT07659366
- **Lead sponsor:** Nexalin Technology
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-22
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-10-25
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07659366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07659366, "HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe Insomnia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07659366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*